Clinical Trials Directory

Trials / Completed

CompletedNCT02031237

MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
University of Michigan Rogel Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess changes in vascular permeability in the brain tumor, and in the surrounding brain, due to radiation therapy, using Magnetic Resonance Imaging (MRI).

Conditions

Interventions

TypeNameDescription
RADIATIONSingle Fraction Stereotactic Radiosurgery (SRS)Intervention will not be assigned by the investigator. Treatment determination will be made prior to study enrollment.
RADIATIONFractionated Whole Brain Radiation Therapy (WBRT)Intervention will not be assigned by the investigator. Treatment determination will be made prior to study enrollment.
RADIATIONFractionated Stereotactic Radiation Therapy (FSRT)Intervention will not be assigned by the investigator. Treatment determination will be made prior to study enrollment.
DEVICEMagnetic Resonance Imaging (MRI) AssessmentsMRI scans will include a routine clinical MRI series.

Timeline

Start date
2005-04-01
Primary completion
2014-05-01
Completion
2014-12-01
First posted
2014-01-09
Last updated
2019-07-26
Results posted
2019-07-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02031237. Inclusion in this directory is not an endorsement.